Advertisement

Mantle Cell Lymphoma | Tumor

CURE’s mantle cell lymphoma (MCL) page features the latest cancer news and updates on mantle cell lymphoma Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in mantle cell lymphoma.

Replacing Agent in R-CHOP Regimen Improves Survival in Mantle Cell Lymphoma

October 26th 2018

The replacement of vincristine with Velcade (bortezomib) in the R-CHOP regimen for the treatment of transplantation-ineligible patients with newly diagnosed mantle cell lymphoma improved overall survival in a final analysis of the LYM-3002 trial.

Two Types of Mantle Cell Lymphoma: Similar, Yet So Different

October 24th 2018

A blood test may help to identify a subset of patients with mantle cell lymphoma and determine the management of outcomes of these individuals.

Novel Combinations Continue to Shape Mantle Cell Lymphoma Treatment Options

October 11th 2018

New drug regimens are not only personalizing the treatment of patients with mantle cell lymphoma, but they’re also improving outcomes, too, explained Chaitra S. Ujjani, M.D.

Finding the Right Therapy for High-Risk Mantle Cell Lymphoma

September 7th 2018

A certain group of patients may not be candidates for common therapies, explained Bijal D. Shah, M.D.

Know the Basics: Mantle Cell Lymphoma

September 6th 2018

This infographic explains some of the basics on mantle cell lymphoma, a type of non-Hodgkin lymphoma.

The Hero Inside Every Cancer Survivor

September 3rd 2018

One of the things I think about is the future. All cancer patients know we have two futures: One where things go well, and one where they don't.

Certain Patients with Mantle Cell Lymphoma May Benefit from Delayed Treatment

August 30th 2018

Deferring treatment may actually be beneficial for some patients with mantle cell lymphoma (MCL), according to recent research.

Two Immunotherapies May Address Unmet Need in Mantle Cell Lymphoma

August 20th 2018

While the treatment landscape of mantle cell lymphoma (MCL) has continued to evolve in recent years, researchers and clinicians alike are still at a loss for curative strategies. But immunotherapy may help.

The Curative Potential of CAR-T Cell Therapy in Mantle Cell Lymphoma

July 26th 2018

Though it is still being tested in clinical trials, CAR-T cell therapy can offer hope for patients with mantle cell lymphoma whose disease relapsed.

Individuals Affected by Blood Cancer Feel Disease is 'Under Control'

July 11th 2018

A national survey demonstrated shared feelings across all blood cancer types about treatment options and their side effects, as well as other social, financial and emotional aspects.

It's an Exciting Time for Mantle Cell Lymphoma

July 9th 2018

There are many exciting advances happening in the field of mantle cell lymphoma.

New Targeted Drugs Nearly Double Survival Time in Mantle Cell Lymphoma

July 5th 2018

Since its classification in 1994, the prognosis for patients diagnosed with mantle cell lymphoma (MCL) was generally poor; however, survival rates have nearly doubled thanks to improvements in the treatment landscape over the past 10 years.

Diagnosis Day Three

June 28th 2018

Moving from shock to action is hard, but it's critical to surviving cancer

Venclexta Shows Potential to Treat Mantle Cell Lymphoma, Unmet Needs Remain

June 25th 2018

Patients with mantle cell lymphoma (MCL) who were treated with Venclexta (venetoclax) showed a slight improvement in response rates compared with chemoimmunotherapy.

My Invisible Coaches

June 21st 2018

Sometimes the people who inspire us are closer than we realize.

Happiness Comes And Goes, But Joy Is Forever

May 18th 2018

Do you know the difference between happiness and joy?

Venclexta and Imbruvica Combo Shows Promise in Mantle Cell Lymphoma

May 7th 2018

A higher complete response rate was seen in patients given both agents compared with those given Imbruvica alone.

Expert Weighs In on What's Next for Mantle Cell Lymphoma

May 6th 2018

The treatment landscape of mantle cell lymphoma is continuing to change. See what expert Andre Goy, M.D., has to say about it.

FDA Approves Drug for Chronic Immune Thrombocytopenia

April 18th 2018

Tavalisse (fostamatinib) was granted approval by the Food and Drug Administration (FDA) for patients with chronic immune thrombocytopenia (ITP) after they had an insufficiencent response to another therapy.

Guilt Is Good, Says One Cancer Survivor

March 23rd 2018

Kevin unleashes his inner guilt for the benefit of you, gentle readers.

You Know You've Been to the Oncologist Too Many Times When...

November 2nd 2017

You walk in and the entire staff yells your name, al la “Norm” of Cheers fame

Exploring Genetic Testing for Mantle Cell Lymphoma

May 15th 2017

Grzegorz S. Nowakowski, M.D., discusses the potential for genetic testing for patients with mantle cell lymphoma.

Run Cancer Run

April 7th 2017

A non-runner explains why running and cancer are the same thing. Except they're not.

Combinations Are Showing Promise in MCL

March 30th 2017

Andre Goy, M.D., discusses some exciting advances in mantle cell lymphoma (MCL).

The Lighter Side Of Cancer

March 5th 2017

In this episode of Cancer With Kevin, we explore the unexpected humor that comes with the general awfulness

The Business Of Cancer

February 18th 2017

Cancer quickly becomes your new, unwelcome, family business

Exploring Combinations in Mantle Cell Lymphoma

January 31st 2017

Adding Ibrance to Imbruvica may be a promising treatment strategy for patients with mantle cell lymphoma, according to a recent study.

Did Your Cancer Transplant Fail? It’s Time To Learn Another Acronym: DLI

November 28th 2016

After two transplants and two relapses, it's time to go down a novel road.

Normal 4.0: Cancer Relapse After Transplant

July 27th 2016

If you've relapsed after you thought you'd been cured, you know what a shock it is. Relapsing twice, after two transplants, turns out to have a surprisingly different effect on Kevin.

Fighting Robots and Fighting Cancer

June 27th 2016

Kevin compares building and fighting robots with enduring and fighting cancer-- a surprising synergy!

NEXT PAGE
PREVIOUS PAGE
Advertisement
Advertisement